Dynavax Technologies Corp (DVAX)
11.79
+0.01
(+0.08%)
USD |
NASDAQ |
Nov 04, 16:00
11.80
+0.01
(+0.08%)
After-Hours: 20:00
Dynavax Technologies Enterprise Value: 1.033B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.033B |
| November 01, 2024 | 1.031B |
| October 31, 2024 | 1.041B |
| October 30, 2024 | 1.068B |
| October 29, 2024 | 1.035B |
| October 28, 2024 | 980.26M |
| October 25, 2024 | 891.15M |
| October 24, 2024 | 899.01M |
| October 23, 2024 | 912.11M |
| October 22, 2024 | 927.84M |
| October 21, 2024 | 926.53M |
| October 18, 2024 | 922.60M |
| October 17, 2024 | 918.66M |
| October 16, 2024 | 933.08M |
| October 15, 2024 | 897.70M |
| October 14, 2024 | 858.38M |
| October 11, 2024 | 854.45M |
| October 10, 2024 | 834.80M |
| October 09, 2024 | 875.42M |
| October 08, 2024 | 880.66M |
| October 07, 2024 | 899.01M |
| October 04, 2024 | 931.77M |
| October 03, 2024 | 954.05M |
| October 02, 2024 | 975.01M |
| October 01, 2024 | 968.46M |
| Date | Value |
|---|---|
| September 30, 2024 | 947.49M |
| September 27, 2024 | 929.15M |
| September 26, 2024 | 909.49M |
| September 25, 2024 | 899.01M |
| September 24, 2024 | 912.11M |
| September 23, 2024 | 943.56M |
| September 20, 2024 | 975.01M |
| September 19, 2024 | 994.67M |
| September 18, 2024 | 956.67M |
| September 17, 2024 | 963.22M |
| September 16, 2024 | 948.81M |
| September 13, 2024 | 951.43M |
| September 12, 2024 | 925.22M |
| September 11, 2024 | 917.35M |
| September 10, 2024 | 954.05M |
| September 09, 2024 | 912.11M |
| September 06, 2024 | 933.08M |
| September 05, 2024 | 909.49M |
| September 04, 2024 | 910.80M |
| September 03, 2024 | 913.42M |
| August 30, 2024 | 957.98M |
| August 29, 2024 | 963.22M |
| August 28, 2024 | 930.46M |
| August 27, 2024 | 956.67M |
| August 26, 2024 | 981.57M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
223.19M
Minimum
Mar 16 2020
2.318B
Maximum
Nov 03 2021
1.026B
Average
1.025B
Median
Sep 27 2022
Enterprise Value Benchmarks
| Biogen Inc | 29.88B |
| Repligen Corp | 7.600B |
| West Pharmaceutical Services Inc | 22.51B |
| XOMA Royalty Corp | 337.44M |
| Xencor Inc | 839.10M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 11.39M |
| Revenue (Quarterly) | 73.80M |
| Total Expenses (Quarterly) | 68.60M |
| EPS Diluted (Quarterly) | 0.08 |
| Gross Profit Margin (Quarterly) | 83.76% |
| Profit Margin (Quarterly) | 15.43% |
| Earnings Yield | 0.93% |
| Normalized Earnings Yield | 0.8895 |